Founded in 2013, MedGenome is a genomics and diagnostics company. The health tech company offers advanced genetic testing across oncology, cardiology, and reproductive health. The soonicorn began with...
Funding stage:
Series E
Last funding:
20/07/2025
Total funding:
$233.00 Mn+
Revenue:
Investors
Employee count:
1,008
Last 90d
1,008
Last 90d
Web traffic:
51.54K
51.54K
Last 30d
Last 30d
MedGenome: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders11
Latest Filing Date17 Dec 2025- Funding Events3
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of MedGenome
As of 18 December 2025, MedGenome's equity is held by 11 shareholders, with the top three being MedGenome Inc., HDFC Life Insurance Company Limited, and Balamani Amma M R.
MedGenome Inc. holds the largest stake in MedGenome at 98.7% as of 18 December 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links